Literature DB >> 20136836

A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.

R D Andó1, B Méhész, K Gyires, P Illes, B Sperlágh.   

Abstract

BACKGROUND AND
PURPOSE: This study was undertaken to compare the analgesic activity of antagonists acting at P2X1, P2X7, and P2Y12 receptors and agonists acting at P2Y1, P2Y2, P2Y4, and P2Y6 receptors in neuropathic, acute, and inflammatory pain. EXPERIMENTAL APPROACH: The effect of the wide spectrum P2 receptor antagonist PPADS, the selective P2X7 receptor antagonist Brilliant Blue G (BBG), the P2X1 receptor antagonist (4,4',4'',4-[carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino))]tetrakis-1,3-benzenedisulfonic acid, octasodium salt (NF449) and (8,8'-[carbonylbis(imino-3,1-phenylenecarbonylimino)]bis-1,3,5-naphthalene-trisulphonic acid, hexasodium salt (NF023), the P2Y12 receptor antagonist (2,2-dimethyl-propionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethyl-propionyloxymethyl)-propylester (MRS2395), the selective P2Y1 receptor agonist ([[(1R,2R,3S,4R,5S)-4-[6-amino-2-(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hex-1-yl]methyl] diphosphoric acid mono ester trisodium salt (MRS2365), the P2Y2/P2Y4 agonist uridine-5'-triphosphate (UTP), and the P2Y4/P2Y6 agonist uridine-5'-diphosphate (UDP) were examined on mechanical allodynia in the Seltzer model of neuropathic pain, on acute thermal nociception, and on the inflammatory pain and oedema induced by complete Freund's adjuvant (CFA). KEY
RESULTS: MRS2365, MRS2395 and UTP, but not the other compounds, significantly alleviated mechanical allodynia in the neuropathic pain model, with the following rank order of minimal effective dose (mED) values: MRS2365 > MRS2395 > UTP. All compounds had a dose-dependent analgesic action in acute pain except BBG, which elicited hyperalgesia at a single dose. The rank order of mED values in acute pain was the following: MRS2365 > MRS2395 > NF449 > NF023 > UDP = UTP > PPADS. MRS2365 and MRS2395 had a profound, while BBG had a mild effect on inflammatory pain, with a following rank order of mED values: MRS2395 > MRS2365 > BBG. None of the tested compounds had significant action on oedema evoked by intraplantar injection of CFA. CONCLUSIONS AND IMPLICATIONS: Our results show that antagonism at P2X1, P2Y12, and P2X7 receptors and agonism at P2Y1 receptors define promising therapeutic strategies in acute, neuropathic, and inflammatory pain respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136836      PMCID: PMC2839268          DOI: 10.1111/j.1476-5381.2009.00596.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  67 in total

1.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 2.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

3.  Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons.

Authors:  Yong Chen; Xiaofei Zhang; Congying Wang; Guangwen Li; Yanping Gu; Li-Yen Mae Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

4.  Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.

Authors:  Maiko Okada; Takayuki Nakagawa; Masabumi Minami; Masamichi Satoh
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

5.  Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.

Authors:  Prisca Honore; Karen Kage; Joseph Mikusa; Andrew T Watt; Joseph F Johnston; Jacqueline R Wyatt; Connie R Faltynek; Michael F Jarvis; Kevin Lynch
Journal:  Pain       Date:  2002-09       Impact factor: 6.961

Review 6.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

7.  Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain.

Authors:  Jane Barclay; Sadhana Patel; Gabriele Dorn; Glen Wotherspoon; Sarah Moffatt; Louise Eunson; Samir Abdel'al; Francois Natt; Jonathan Hall; Janet Winter; Stuart Bevan; William Wishart; Alyson Fox; Pam Ganju
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 8.  ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4.

Authors:  Kazuhide Inoue; Makoto Tsuda; Schuichi Koizumi
Journal:  J Pharmacol Sci       Date:  2004-02       Impact factor: 3.337

9.  TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons.

Authors:  Kenzo Tsuzuki; Ariel Ase; Philippe Séguéla; Terumasa Nakatsuka; Cong-Yi Wang; Jin-Xiong She; Jianguo G Gu
Journal:  J Neurophysiol       Date:  2003-06       Impact factor: 2.714

10.  Effect of resiniferatoxin on the noxious heat threshold temperature in the rat: a novel heat allodynia model sensitive to analgesics.

Authors:  Róbert Almási; Gábor Pethö; Kata Bölcskei; János Szolcsányi
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more
  34 in total

Review 1.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

2.  C terminus of the P2X7 receptor: treasure hunting.

Authors:  Helio Miranda Costa-Junior; Flávia Sarmento Vieira; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2011-01-27       Impact factor: 3.765

3.  Chronic inflammatory pain upregulates expression of P2Y2 receptor in small-diameter sensory neurons.

Authors:  Huiqin Zhu; Yi Yu; Lingyan Zheng; Lu Wang; Chenli Li; Jiangyuan Yu; Jing Wei; Chuang Wang; Junfang Zhang; Shujun Xu; Xiaofei Wei; Wei Cui; Qinwen Wang; Xiaowei Chen
Journal:  Metab Brain Dis       Date:  2015-06-12       Impact factor: 3.584

Review 4.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

5.  Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.

Authors:  Zsuzsanna Bohár; Gábor Nagy-Grócz; Annamária Fejes-Szabó; Lilla Tar; Anna M László; Alexandra Büki; Nikolett Szabadi; Veronika Vraukó; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575

6.  Transmission pathways and mediators as the basis for clinical pharmacology of pain.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Tyler A Smith; Nicholas P Dueck; Mitchell J Kerfeld; Zakary J Hambsch; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-07-04       Impact factor: 5.045

7.  CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat Spinal Dorsal Horn Neurons.

Authors:  Jingdong Long; Xiaolu Lei; Meiyun Chen; Shulei Yang; Tao Sun; Junwei Zeng; Deqian Yu; Hong Tian; Xiaohong Liu
Journal:  Neurochem Res       Date:  2017-11-10       Impact factor: 3.996

Review 8.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

9.  P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.

Authors:  Yumei Luo; Cheng Feng; Jing Wu; Yongxing Wu; Dong Liu; Jie Wu; Fei Dai; Jun Zhang
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

10.  Enhancement of purinergic signalling by excessive endogenous ATP in resiniferatoxin (RTX) neuropathy.

Authors:  Chih-Lung Lin; Yaw-Syan Fu; Tin-Hsin Hsiao; Yu-Lin Hsieh
Journal:  Purinergic Signal       Date:  2012-12-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.